Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note released on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Roth Capital downgraded shares of Cyclacel Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 23rd. Check […]
StockNews.com initiated coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note released on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Roth Capital downgraded shares of Cyclacel Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 23rd. Check […]
